Articles On Immutep (ASX:IMM)

S&P/ASX 200 Index (ASX: XJO) stocks, taken together, moved higher in June. In afternoon trade on Friday, with just hours left before the ASX closes shop for the month, the benchmark index is up 1.4% since the closing bell rang on 31 Ma...

The S&P/ASX 200 Index (ASX: XJO) is having a better session on Friday. In afternoon trade, the benchmark index is up a solid 0.65% to 7,811.1 points. Four ASX shares that have failed to follow the market higher today are listed below....

Sometimes, people like me can make investing seem way too complicated. Hopefully not me, personally – over the last dozen years of my professional life, I've aimed to make investing as simple as possible for our readers and members – bu...

FleetPartners Group Ltd (ASX: FPR) shares are trading 3% higher in morning trade on Friday after it was confirmed Mitsubishi Motors has acquired a 5% stake in the company. The Japanese automotive giant announced on Monday that it has a...

Fortunately for income investors, the Australian share market is one of the most generous in the world when it comes to dividends. Year in, year out, countless ASX listed companies share a portion of their profits with their lucky sharehold...

The rate of inflation in Australia continues to be stronger than what the Reserve Bank of Australia (RBA) would like, which may have a negative knock-on effect on ASX shares. The latest monthly reading showed that inflation had accelerated...

ASX200 falls fast for a second session after inflation steals the air in the room 7 of 11 ASX sectors lower, with InfoTech the only standout in the plus column Small caps led by Iris Metals and Bellavista Resources   Local markets have...

While the market closed in the red on a down day for the ASX, it wasn’t as bad as futures had predicted after the bourse pared intraday losses. All eyes will be on the US tonight. At 10:30 PM Sydney time, the US will release data on man...

When you first start out investing, you can invest in fledgling growth stocks and small caps. That's because if things don't go quite to plan, you have plenty of time to recoup your losses. However, if you're already in retirement, you cann...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a disappointing decline. At the time of writing, the benchmark index is down 1% to 7,704.4 points. Four ASX shares that are falling more than most today are li...

Immutep sinks 35pc despite positive TACTI-003 Phase IIb trial results Investors may have had higher expectations, leading to the market reaction The trial evaluated efti with KEYTRUDA for first-line head and neck cancer   Immutep (ASX:IMM...

Clinical-stage biotechnology company Immutep (ASX: IMM) has released top-line results from a Phase IIb trial evaluating eftilagimod alfa (efti) in combination with anti-PD-1 therapy KEYTRUDA (pembrolizumab) as a first-line treatment for rec...

Immutep Ltd (ASX: IMM) shares are having a day to forget on Thursday. In morning trade, the ASX healthcare stock is down a whopping 47% to a 52-week low of 23 cents. Why is this ASX healthcare stock crashing? Investors have been racing to t...

  Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt, Chief Scientific Officer Professor Frédéric Triebel, Chief Medical Officer Dr Florian Vogl, and Senior Vice President Strategic Development Christian Mueller present on Immu...

ASX to fall by 1pc when the market opens Amazon reaches $2 trillion market cap for the first time Aussie property market to remain strong in 2024   The ASX 200 is poised to fall sharply when the market opens on Thursday despite rallies in...

BrainChip Holdings Ltd (ASX: BRN) shares have had a turbulent first half of the year. Despite showing a 16% gain this year to date, nearly all of this occurred in the first two months of the year. After reaching a 52-week high of 54 cent...

Every investor has a different risk appetite. Some investors play it safe and buy low risk, defensive ASX stocks. Others are willing to risk a little for stronger potential returns. And a handful will seek the huge potential returns on offe...

Goldman Sachs is one of the most highly respected investment banks out there. Its analysts scour the globe for investment opportunities and then recommend them to investors. While the broker has buy ratings on a number of ASX shares, it has...

The ASX200 closed up 0.4% – thanks to a very small rise in Australia’s latest Gross Domestic Product data. Quarterly GDP rose just 0.1%, which is the slowest pace of GDP growth in one-and-a-half-years.  As far as the sectors went toda...

Aussie shares rise in arvo trade Resources sectors weigh, Real Estate adds 2pc GDP lowest in 40 years ex. COVID   The local bourse has come home with a sail wet on Wednesday with the ordinariness of our economy bringing market joy as it d...

The S&P/ASX 200 Index (ASX: XJO) is back on form on Wednesday and pushing higher. In afternoon trade, the benchmark index is up 0.4% to 7,768.7 points. Four ASX shares that have failed to follow the market higher today are listed below...

The Xero Ltd (ASX: XRO) share price is paused from trade on Wednesday morning. Why is the Xero share price paused? The company's shares are paused at present after Xero announced a major convertible notes offering. According to the release,...

Immutep (ASX:IMM) has launched a fully underwritten equity raising of approximately $100 million and a Phase 3 clinical trial collaboration with MSD.

 S&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biotech stocks We take a look at the ASX biotech winners for the month   The  S&P/ASX 200 Health Care [XHJ] closed flattish for the month o...

ASX starts June positively, extending May gains  Property prices in Australia rose by 0.8% in May, with Sydney remaining the most expensive city Lovisa plunges by -10% as John Cheston takes over as CEO   The ASX has started the month of...

03 Jun 2024 - A snapshot of the stocks on the move, featuring Immutep (ASX:IMM), INOVIQ (ASX:IIQ) and Eastern Metals (ASX:EMS).

Immutep has launched a capital raise aiming to boost its war chest by $100 million to progress late-stage drug trials for lung cancer sufferers. The biotechnical company said apart from funding for its Phase 3 TATACTI004 trial encompassi...

Research shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase the risk of dementia We look at the best performing ASX stocks over the past month    The phrase ‘you are what you eat’ was coined almost a c...

The All Ordinaries Index (ASX: XAO) is up a solid 0.5% on Monday, with one ASX All Ords share doing plenty of the heavy lifting. Shares in the sports betting company closed Friday at 45.5 cents. In morning trade today, they rocketed to 5...

If you have a higher than average risk tolerance, then it could be worth checking out the ASX penny stock listed below. Just over three years ago, this company was far from a penny stock with a share price over $15.00. But a lot has happene...

If you're looking for some big returns to supercharge your portfolio, then read on. That's because analysts at Bell Potter have just put buy ratings on three ASX stocks and tipped them to rise between 30% and 90%. Here's what the broker is...

Immutep shares promising early results from Phase 2 trial on soft tissue sarcoma (STS) This trial is the first of its kind, and evaluates IMM’s lead drug, efti STS is a rare cancer with limited treatment options   The clinical stage immun...

02 May 2024 - A snapshot of the stocks on the move, featuring Krakatoa Resources (ASX:KTA), Immutep (ASX:IMM) and ABx Group (ASX:ABX).

  To register for Friday's webinar click here. Krakatoa Resources (ASX:KTA) has announced that new niobium-REE gravity target has been identified at Mt Clere. The assays show an extensive 40 km long target catchment area potentially prospec...

Immutep (ASX:IMM) has announced initial encouraging data from EFTISARC-NEO, a Phase 2 investigator-initiated trial of eftilagimod alpha in combination with radiotherapy, a standard-of-care treatment, plus MSD's KEYTRUDA (pembrolizum...

ASX Health sector was in correction territory in April Why is the health sector different from other sectors? We look at the best performing ASX health stocks for the month   The S&P/ASX 200 Health Care [XHJ] had a soft month in April...

The S&P/ASX 200 Index (ASX: XJO) is on form again on Tuesday and pushing higher. At the time of writing, the benchmark index is up 0.2% to 7,651.4 points. Four ASX shares that have failed to follow the market higher today are listed b...

Pointsbet Holdings Ltd (ASX: PBH) shares are having a very tough session on Tuesday. In morning trade, the sports betting company's shares crashed as much as 45% to 45.5 cents. The company's shares have recovered a touch since then but rema...

A week or so ago, my young bloke's school invited parents to join the kids on a trip to the local cemetery, to take part in an ANZAC commemoration the school calls Honour Our Fallen. The kids were asked to talk about a family member who was...

There’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to control sebum production We look at the best and worst performing ASX health stocks in the past month   Scientists have made a significant b...

It was a mildly disappointing Wednesday for ASX investors today, with the S&P/ASX 200 Index (ASX: XJO) recording a slight loss. After spending most of the day in green territ...

The S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. In afternoon trade, the benchmark index is up 0.2% to 7,698.4 points. Four ASX shares that are rising more than most today are listed below. Here's why they are rac...

24 Apr 2024 - A snapshot of the stocks on the move, featuring Immutep (ASX:IMM; NASDAQ:IMMP), Western Mines Group (ASX:WMG) and Industrial Minerals (ASX:IND).

  Immutep (ASX:IMM; NASDAQ:IMMP) has announced preliminary topline results from Cohort B of the TACTI-003 Phase IIb trial. The trial evaluates efti in combination with MSD’s anti-PD-1 therapy KEYTRUDA® as first-line treatment for recurrent/...

  ASX to extend gains on Wednesday after Wall Street bounced back Tesla surged by 11pc after releasing quarterly results And where will the S&P 500 index be at year end?   Aussie shares are set to extend their good run on Wednesday a...

  The ASX close higher as unemployment rate came in lower than expected Miners rally, led by BHP as the giant released its Q3 report Nimy Resources up 50pc after reporting promising intercepts   The ASX added 0.5% on Thursday as the unemp...

  Nimy Resources (ASX:NIM) advises that drilling at Block 3 within its Mons project in WA has returned intersections of elevated copper, gold, silver mineralisation in massive sulphides plus high-grade gallium and rare earth oxide mineralis...

Immutep Limited (ASX:IMM) has entered into an agreement with the Centre for Human Drug Research (CHDR) in the Netherlands to perform a first-in-human clinical study of IMP761.

The ASX200 slipped into the red – but only by 0.09 of a per cent at close – with Utilities sporting a healthier disposition, up 2.84 per cent, as energy and healthcare slumped around half a per cent. In the green FRE  Australian he...

The ASX200 is up around a quarter of a per cent – beating futures predictions by about half a per cent. Utilities is up around 1.9 per cent – whilst energy and materials are falling off the pace. New Zealand’s inflation data has hit i...